跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 723 条关于
“Provectus Biopharmaceuticals”
全部
723
临床试验
38
药物
189
机构
101
资讯
395
去年
Provectus Biopharmaceuticals Launches VisiRose for Ophthalmic Therapies
3个月前
Provectus Biopharmaceuticals to Deliver Broad Strategic Update at 2026 Annual Stockholder Meeting
11个月前
Provectus Biopharmaceuticals Launches Preclinical Study of Oral PV-10 for Bladder Cancer Treatment
去年
VisiRose Secures $3 Million Seed Funding to Advance Rose Bengal-Based Ocular Therapeutics
去年
Provectus' PV-10 Immunotherapy Shows Promise in Head and Neck Cancer Through Novel Cell Death Mechanism
去年
VisiRose Launches Rose Bengal-Based Therapy for Severe Eye Infections
11个月前
PV-10 Shows Promise as Novel STING-Pathway Vaccine Adjuvant in University of Calgary Research
4个月前
Rose Bengal Sodium Shows Light-Independent Activity Against MRSA and Biofilms in New U.S. Patent, Expanding VisiRose's Ophthalmic Pipeline
4个月前
Oral PV-10 Shows Promising Anti-Tumor Activity in Preclinical Bladder Cancer Study
去年
Angitia Biopharmaceuticals Doses First Patient in Phase 2 Trial of AGA2118 for Osteoporosis
第 1 页,共 40 页
上一页
下一页